fast heartbeats
Michelet, A., Mowla, M., Amo-Brown, B
Additional Cost Management Strategies Organizations exploring GLP-1 coverage are also considering targeted cost-control measures, including: Setting clinical qualification standards based on BMI and related conditions Establishing duration or lifetime coverage limits where allowed Adjusting copays or deductibles for obesity-related medications Favoring lower-utilization or lower-cost therapeutic alternatives within the formulary Evaluating alternative treatments such as bariatric surgery, which may produce durable outcomes at comparable costs to a year of medication therapy These strategies allow employers to maintain access while aligning coverage with financial objectives

CrossRef Efficacy and safety of anti-obesity drugs in metabolic dysfunction-associated steatotic liver disease: An updated review Marcio J Concepcin-Zavaleta, Jenyfer M Fuentes-Mendoza, Jhean G Gonzles-Yovera, Gemma Y Ruvalcaba-Barbosa, Leonardo D Cura-Rodrguez, Josu S Gonzlez-Rodrguez, Luis A Concepcin-Urteaga, Aranza I Prez-Reyes, Juan Eduardo Quiroz-Aldave, Jos Paz-Ibarr World Journal of Gastroenterology.2025;[Epub] CrossRef Paliurus ramosissimus Leaf Extract Inhibits Adipocyte Differentiation In Vitro and In Vivo High-Fat Diet-Induced Obesity Through PPAR Suppression Shin-Hye Kim, Tae Hyun Son, Hye-Lim Shin, Dongsoo Kim, Gwang Hun Park, Jeong Won Seo, Hwan-Gyu Kim, Sik-Won Choi Pharmaceuticals.2025